MedTrace Logo

Spiration Valve System 9 mm European Post Market Evaluation Study

NCT03008226 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-01-02

No results posted yet for this study

Summary

The purpose of this observational study is to investigate the efficacy of 9 mm intrabronchial valve treatment in patients with heterogeneous emphysema and to gain further insights and experience on the treatment with this valve size.

Conditions

  • Emphysema

Interventions

DEVICE

Implementation of 9 mm intrabronchial valves

Sponsors & Collaborators

  • Lung Clinic Hemer

    collaborator OTHER

  • Asklepios Kliniken Hamburg GmbH

    collaborator OTHER

  • Otto Wagner Hospital

    collaborator OTHER

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Felix Herth, Prof.Dr.med. · University Heidelberg

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-01-31
Completion
2017-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03008226 on ClinicalTrials.gov